Wednesday 16 July 2014          10:30 – 12:00
Track 2 - Rethinking Mood Therapeutics- Novel pharmacological approaches for Anxiety and Depression

Chair: Nicolas Singewald & John Cryan

Rescue of impaired fear extinction by targeting epigenetic mechanisms in a genetic mouse model
Nicolas Singewald

Translational support of a role of endocannabinoids in anxiety and its treatment
Andrew Holmes

Revising antidepressant therapy: from serotonin to glutamate
Greger Wegener

Behavioural and biological validation of an animal model of obsessive-compulsive disorder (OCD)
Brian Harvey

microRNAs as Novel therapeutic targets for anxiety and depression
John Cryan

South African Society for Basic and Clinical Pharmacology Section 21 Company, Registration no. 2006/029963/08 Registry Office: Alchemy Financial Services Unit 3 Bush Hill Office Park, Jan Frederick Ave, Honeydew 2154

© Scatterlings Conference and Events